| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.28 | 0.09 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |